The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
After finishing at $282.2 in the prior trading day, AMGEN Inc (NASDAQ: AMGN) closed at $298.5, up 5.78%. In other words, the price has increased by $5.78 from its previous closing price. On the day, 4.83 million shares were traded. AMGN stock price reached its highest trading level at $301.66 during the session, while it also had its lowest trading level at $283.0.
Ratios:
Our goal is to gain a better understanding of AMGN by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 20.02 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 15.15. For the most recent quarter (mrq), Quick Ratio is recorded 0.98 and its Current Ratio is at 1.31. In the meantime, Its Debt-to-Equity ratio is 7.57 whereas as Long-Term Debt/Eq ratio is at 7.24.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Aug 20 ’25 when Grygiel Nancy A. sold 1,267 shares for $296.99 per share. The transaction valued at 376,280 led to the insider holds 7,209 shares of the business.
Grygiel Nancy A. bought 1,267 shares of AMGN for $372,909 on Aug 20 ’25. On Jun 05 ’25, another insider, Khosla Rachna, who serves as the SVP, Business Development of the company, sold 1,500 shares for $289.68 each. As a result, the insider received 434,520 and left with 8,162 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AMGN now has a Market Capitalization of 160701022208 and an Enterprise Value of 208877010944. As of this moment, AMGEN’s Price-to-Earnings (P/E) ratio for their current fiscal year is 24.42, and their Forward P/E ratio for the next fiscal year is 13.80. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 5.88. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.62 while its Price-to-Book (P/B) ratio in mrq is 21.63. Its current Enterprise Value per Revenue stands at 5.982 whereas that against EBITDA is 12.935.
Stock Price History:
The Beta on a monthly basis for AMGN is 0.48, which has changed by -0.11112511 over the last 52 weeks, in comparison to a change of 0.17342639 over the same period for the S&P500. Over the past 52 weeks, AMGN has reached a high of $335.88, while it has fallen to a 52-week low of $253.30. The 50-Day Moving Average of the stock is 3.59%, while the 200-Day Moving Average is calculated to be 3.69%.
Shares Statistics:
The stock has traded on average 2.20M shares per day over the past 3-months and 3146580 shares per day over the last 10 days, according to various share statistics. A total of 538.30M shares are outstanding, with a floating share count of 537.30M. Insiders hold about 0.20% of the company’s shares, while institutions hold 82.14% stake in the company. Shares short for AMGN as of 1757894400 were 13202457 with a Short Ratio of 5.99, compared to 1755216000 on 10873563. Therefore, it implies a Short% of Shares Outstanding of 13202457 and a Short% of Float of 2.4600001.
Dividends & Splits
In the trailing 12 months, AMGN’s forward annual dividend rate was 9.26, compared to 9.39 this year. Against a Trailing Annual Dividend Yield of 0.032813605. The stock’s 5-year Average Dividend Yield is 3.05. The current Payout Ratio is 119.05% for AMGN, which recently paid a dividend on 2025-08-22 with an ex-dividend date of 2025-08-22. Stock splits for the company last occurred on 1999-11-22 when the company split stock in a 2:1 ratio.
Earnings Estimates
AMGEN Inc (AMGN) is currently under the scrutiny of 24.0 analysts, each contributing to the ongoing evaluation of its stock.The consensus estimate for the next quarter is $5.12, with high estimates of $5.74 and low estimates of $4.83.
Analysts are recommending an EPS of between $21.62 and $20.64 for the fiscal current year, implying an average EPS of $21.08. EPS for the following year is $21.6, with 30.0 analysts recommending between $23.2 and $20.31.
Revenue Estimates
22 analysts predict $8.98B in revenue for. The current quarter. It ranges from a high estimate of $9.2B to a low estimate of $8.78B. As of. The current estimate, AMGEN Inc’s year-ago sales were $8.5BFor the next quarter, 22 analysts are estimating revenue of $9.36B. There is a high estimate of $9.66B for the next quarter, whereas the lowest estimate is $9.08B.
A total of 29 analysts have provided revenue estimates for AMGN’s current fiscal year. The highest revenue estimate was $36.18B, while the lowest revenue estimate was $35.26B, resulting in an average revenue estimate of $35.7B. In the same quarter a year ago, actual revenue was $33.42BBased on 29 analysts’ estimates, the company’s revenue will be $36.31B in the next fiscal year. The high estimate is $37.92B and the low estimate is $34.74B.
